Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1342.3% | +431.5% | 2 / 3 | -28.7% | +2.16 pp | +0.25 pp | +1.4% | 2.06 | 125.11 | 1.487 | −28,7% | 4,6 | +291,1% | 125.11 | 45.33 | +176,0% |
| Pts | 12 | 12 | 8 | 0 | 8 | 8 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 18.900 (close price on 2026-10-19)EPS (TTM): 151,1
Financial charts
1.Revenue & growth
VND bn1.487Q2/26
1.Revenue & growth
VND bn1.487Q2/26
2.Profit & growth
VND bn4,29Q2/26
3.Profit mix (Penman)
VND bn30,6Q2/26
4.Margins & cost structure
%6.0%Q2/26
5.Returns & cash cycle
% · days0.1%Q2/26
6.Earnings quality & cash
VND bn361Q2/26
7.Asset structure
VND bn3.945Q2/26
8.Funding & debt health
VND bn · times3.945Q2/26
9.Revenue backlog
VND bn31,7Q2/26
10.Valuation
times · %125,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %45Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-23.9%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26